Published in Infect Immun on August 25, 2014
Vaccine targets against Moraxella catarrhalis. Expert Opin Ther Targets (2015) 0.84
Serum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in children. Vaccine (2015) 0.78
The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis. Infect Immun (2015) 0.77
Expression of the Oligopeptide Permease Operon of Moraxella catarrhalis Is Regulated by Temperature and Nutrient Availability. Infect Immun (2015) 0.75
Bacterial peptide transporters: Messengers of nutrition to virulence. Virulence (2016) 0.75
ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence. PLoS One (2016) 0.75
The oppD gene and putative peptidase genes may be required for virulence in Mycoplasma gallisepticum. Infect Immun (2017) 0.75
Do we need a vaccine against Moraxella catarrhalis in chronic lung disease? What are the options and opportunities? Vaccine (2017) 0.75
ABC transporters: from microorganisms to man. Annu Rev Cell Biol (1992) 19.49
Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev (2002) 17.58
Antibacterial resistance worldwide: causes, challenges and responses. Nat Med (2004) 10.46
Global burden of COPD: risk factors, prevalence, and future trends. Lancet (2007) 9.50
Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J Bacteriol (1993) 8.75
Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J (2006) 6.34
Deaths: final data for 2010. Natl Vital Stat Rep (2013) 5.95
Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med (2008) 4.33
Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J (2006) 3.42
Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously. Nucleic Acids Res (2004) 3.30
Thermodynamic stability of carbonic anhydrase: measurements of binding affinity and stoichiometry using ThermoFluor. Biochemistry (2005) 3.16
Nitric oxide in health and disease of the respiratory system. Physiol Rev (2004) 3.15
How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev (2008) 3.12
Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med (2005) 2.61
Biofilm susceptibility to antimicrobials. Adv Dent Res (1997) 2.59
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J (2008) 2.51
The burden of otitis media. Vaccine (2000) 2.43
Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev (2002) 2.43
Arginine methylation at a glance. J Cell Sci (2007) 2.24
ATP-binding cassette transporters are targets for the development of antibacterial vaccines and therapies. Infect Immun (2004) 2.15
Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis (2009) 2.15
Blocking NO synthesis: how, where and why? Nat Rev Drug Discov (2002) 1.95
Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect (2000) 1.94
OppA of Listeria monocytogenes, an oligopeptide-binding protein required for bacterial growth at low temperature and involved in intracellular survival. Infect Immun (2000) 1.90
Otitis media and its consequences: beyond the earache. Lancet Infect Dis (2010) 1.68
Fitness of Escherichia coli during urinary tract infection requires gluconeogenesis and the TCA cycle. PLoS Pathog (2009) 1.67
Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest (2002) 1.67
Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. MBio (2010) 1.59
The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther (2007) 1.59
MppA, a periplasmic binding protein essential for import of the bacterial cell wall peptide L-alanyl-gamma-D-glutamyl-meso-diaminopimelate. J Bacteriol (1998) 1.58
Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen. J Bacteriol (2010) 1.57
The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis. Genome Res (2007) 1.40
Rapid and simple protein-stability screens: application to membrane proteins. Acta Crystallogr D Biol Crystallogr (2006) 1.36
Bacterial oligopeptide-binding proteins. Cell Mol Life Sci (2003) 1.33
Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis (1992) 1.32
Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: investigation of the indirect pathogenic role of beta-lactamase-producing moraxellae by use of a continuous-culture biofilm system. Antimicrob Agents Chemother (1998) 1.32
From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases. BMC Pulm Med (2009) 1.24
Arginine in asthma and lung inflammation. J Nutr (2004) 1.19
Molecular aspects of Moraxella catarrhalis pathogenesis. Microbiol Mol Biol Rev (2009) 1.19
Metabolic analysis of Moraxella catarrhalis and the effect of selected in vitro growth conditions on global gene expression. Infect Immun (2007) 1.17
The ABC transporter protein OppA provides protection against experimental Yersinia pestis infection. Infect Immun (2006) 1.14
The lung in the balance: arginine, methylated arginines, and nitric oxide. Am J Physiol Lung Cell Mol Physiol (2006) 1.08
Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children. Pediatr Infect Dis J (2003) 1.08
Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect Immun (2008) 1.06
Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics (2006) 1.00
COPD and the response of the lung to tobacco smoke exposure. Pulm Pharmacol Ther (2010) 0.99
Plasmid pWW115, a cloning vector for use with Moraxella catarrhalis. Plasmid (2006) 0.98
Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. Am J Respir Crit Care Med (2011) 0.98
An aerosol challenge mouse model for Moraxella catarrhalis. Vaccine (1999) 0.96
Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen. Infect Immun (2010) 0.96
Defined medium for Moraxella (Branhamella) catarrhalis. Appl Environ Microbiol (1986) 0.95
His-311 and Arg-559 are key residues involved in fatty acid oxygenation in pathogen-inducible oxygenase. J Biol Chem (2008) 0.92
Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. Am J Respir Cell Mol Biol (2006) 0.92
Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract. Infect Immun (2013) 0.88
Moraxella catarrhalis - pathogen or commensal? Adv Exp Med Biol (2011) 0.87
Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis. Vaccine (2009) 0.86
Virulence mechanisms of Moraxella in the pathogenesis of infection. Curr Opin Infect Dis (2009) 0.85
Altered expression of oligopeptide-binding protein (OppA) and aminoglycoside resistance in laboratory and clinical Escherichia coli strains. J Med Microbiol (2000) 0.84
Molecular pathogenesis of infections caused by Moraxella catarrhalis in children. Swiss Med Wkly (2012) 0.80
Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2. BMC Microbiol (2013) 0.78
Outer membrane porin M35 of Moraxella catarrhalis mediates susceptibility to aminopenicillins. BMC Microbiol (2009) 0.78